These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31102954)

  • 1. Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr
    Burke AC; Sutherland BG; Telford DE; Morrow MR; Sawyez CG; Edwards JY; Huff MW
    Atherosclerosis; 2019 Jul; 286():60-70. PubMed ID: 31102954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair-Fed Ldlr
    Burke AC; Telford DE; Edwards JY; Sutherland BG; Sawyez CG; Huff MW
    Mol Nutr Food Res; 2019 Mar; 63(6):e1800833. PubMed ID: 30578663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ mice.
    Assini JM; Mulvihill EE; Sutherland BG; Telford DE; Sawyez CG; Felder SL; Chhoker S; Edwards JY; Gros R; Huff MW
    J Lipid Res; 2013 Mar; 54(3):711-724. PubMed ID: 23269394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese
    Burke AC; Sutherland BG; Telford DE; Morrow MR; Sawyez CG; Edwards JY; Drangova M; Huff MW
    J Lipid Res; 2018 Sep; 59(9):1714-1728. PubMed ID: 30008441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet.
    Merat S; Casanada F; Sutphin M; Palinski W; Reaven PD
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1223-30. PubMed ID: 10323773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
    Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
    Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
    Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringin, the major grapefruit flavonoid, specifically affects atherosclerosis development in diet-induced hypercholesterolemia in mice.
    Chanet A; Milenkovic D; Deval C; Potier M; Constans J; Mazur A; Bennetau-Pelissero C; Morand C; Bérard AM
    J Nutr Biochem; 2012 May; 23(5):469-77. PubMed ID: 21684135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques.
    Huang A; Young TL; Dang VT; Shi Y; McAlpine CS; Werstuck GH
    Atherosclerosis; 2017 Nov; 266():103-112. PubMed ID: 29024862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
    Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase 3α deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet-fed low density lipoprotein receptor-deficient mice.
    Banko NS; McAlpine CS; Venegas-Pino DE; Raja P; Shi Y; Khan MI; Werstuck GH
    Am J Pathol; 2014 Dec; 184(12):3394-404. PubMed ID: 25451156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anionic nanoliposomes reduced atherosclerosis progression in Low Density Lipoprotein Receptor (LDLR) deficient mice fed a high fat diet.
    Krishna SM; Moxon JV; Jose RJ; Li J; Sahebkar A; Jaafari MR; Hatamipour M; Liu D; Golledge J
    J Cell Physiol; 2018 Oct; 233(10):6951-6964. PubMed ID: 29741759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
    Coenen KR; Hasty AH
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and ApoE(-/-) mice.
    Ryu SK; King TJ; Fujioka K; Pattison J; Pashkow FJ; Tsimikas S
    Atherosclerosis; 2012 May; 222(1):99-105. PubMed ID: 22406426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.
    Tsimikas S; Shortal BP; Witztum JL; Palinski W
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):689-97. PubMed ID: 10712392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrus flavonoid naringenin reduces mammary tumor cell viability, adipose mass, and adipose inflammation in obese ovariectomized mice.
    Ke JY; Banh T; Hsiao YH; Cole RM; Straka SR; Yee LD; Belury MA
    Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28370954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
    Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.